Epstein Secrets

no conflict because Innate had no business before U.S. regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have ben

946 SDNY News Clips, Wednesday, July 31, 2019 Thompson never gave the second company any Bitcoin and did not return its money, prosecutors said. "Jon Thompson induced investors to engage in cryptocurrency transactions through his company, Volantis Market Making, by touting a transaction structure that woul

no conflict because Innate had no business before U.S. regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have ben

ving any Bitcoin in return, prosecutors allege. Thompson never gave the second company any Bitcoin and did not return its money, prosecutors said. "Jon Thompson induced investors to engage in cryptocurrency transactions through his company, Volantis Market Making, by touting a transaction structure that woul

no conflict because Innate had no business before U.S. regulators. But in 2017, the company practically beamed that it had "received clearance from the U.S. Food and Drug Administration for the Company's Investigational New Drug (IND) application lodged last month." The fact that Collins' role in the legislation could also have ben

--- SDNY News Clips, Wednesday, July 31, 2019 Thompson never gave the second company any Bitcoin and did not return its money, prosecutors said. "Jon Thompson induced investors to engage in cryptocurrency transactions through his company, Volantis Market Making, by touting a transaction structure that woul